Ziad Bakouny, MD, MSc
@ZiadBakouny
Followers
3K
Following
50K
Statuses
8K
PGY-4 Heme/Onc @MSK_DeptOfMed | via @USJLiban @DanaFarber @BrighamMedRes | @ASCO #IMG CoP & #JCOCCI Assoc Editor | Cancer Genomics | FCOI: https://t.co/dYsEwGGqP1
Boston, MA
Joined February 2012
Please join us for our 2nd annual meeting of the @ASCO IMG Community of Practice! We have a terrific agenda and lineup of speakers! #ASCO24
@NazliDizman @DrChoueiri @NarjustFlorezMD @EileenMOReilly @jamecancerdoc @thenasheffect @GIcancerDoc @montypal @neerajaiims @MSKCancerCenter @MSK_DeptOfMed
🚨Save the date🚨 ⏰May 31st, 4-6 PM CST 📍Room S103, McCormick Place We are super excited to announce the 2nd annual meeting of the @ASCO #IMG Community of Practice this upcoming #ASCO24🌟 Join our all-star speakers to discuss barriers & opportunities for IMGs in #oncology!
1
11
49
@srviswanathan @NatMetabolism @LironBarPeled @DanaFarberNews @jiaoli43141960 @Sadagopan_A @DrPrateekKhanna @YasminLaimon @Cary_Weiss @m_achom @DrChoueiri @LabSignoretti @DanaFarber_GU Awesome work! Congratulations Jiao, Srini et al!
0
0
1
RT @srviswanathan: 🚨 New study! 🚨Excited to share our research on #translocationRCC #tRCC published in @NatMetabolism, in collaboration wit…
0
42
0
1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author @BraunMDPhD @YaleCancer and #PatrickOtt #DerinKeskin #CatherineWu @DanaFarber
@DanaFarber_GU @OncoAlert @DFCI_NeoVax
0
1
15
RT @DrChoueiri: 1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tum…
0
203
0
RT @lydfinley: Massive work from Jess Spinelli @UMassChan demonstrating a SECOND electron carrier in the mammalian ETC
0
64
0
RT @DrRosenbergMSK: The MSK GU Service recently celebrated the illustrious career of Dr. Dean Bajorin. We will miss his wisdom, insight, hu…
0
15
0
RT @JCOCCI_ASCO: Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line #Nivolumab Plus #Ipilimumab i…
0
2
0
@PavlosMsaouel @NatureComms @PGrivasMDPhD @montypal @VivekSubbiah @IamLinghua @JadChahoud @KidneyCancer @kidneycan @kcCURE @neerajaiims @rahulshethmd Congratulations @PavlosMsaouel!! Looks awesome
1
0
3
RT @PavlosMsaouel: 1/5 Thrilled to share in @NatureComms the clinical outcomes and scRNA-seq correlatives our phase I triplet immunotherapy…
0
47
0
RT @TurajlicLab: (1/14) ❓How do the tumor genome, transcriptome, and TME jointly evolve in clear cell renal cell carcinoma (ccRCC)? 🚨As pa…
0
35
0
RT @ReneeSaliby: 1/ 🧵Excited to share our latest study published in @NatureCancer co-led with amazing co-first authors and friends @TJammih…
0
61
0
@DrChoueiri @DanaFarber_GU @srviswanathan @harvardmed @DanaFarberNews @DanaFarber @VasanthiViswa Congratulations Srini!!
0
0
2
RT @DrChoueiri: 1/ Results from #LITESPARK-003 cohort 1 (1st Line) are out @TheLancetOncol! This phase II trial examined HIF2 inh Belzutifa…
0
40
0
RT @VanAllenLab: Here's our latest, led by Drs. Riaz Gillani & @RyanLCollins13 - we studied a type of inherited genetic event (structural v��
0
47
0
RT @DrChoueiri: END OF YEAR TOP ALL CANCER TRIALS in 2024! JUST in on 1 JAN 2025: Paper 1: #neoadjuvant checkpoint inhibitor Phase 3 tr…
0
215
0
RT @DrChoueiri: IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembroliz…
0
242
0
RT @JasmineKambojMD: Sharing this survey around understanding challenges for IMGs while they are also trying to be parents In a foreign lan…
0
11
0
RT @DrChoueiri: And NOW, TOP 5 PROSTATE CANCER trials of 2024! 1) The ARANOTE trial shows darolutamide + ADT improves rPFS in mHSPC by 46%…
0
170
0
RT @KeshariLab: What if you could quantitatively probe multiple redox pathways in a spatially resolved way in vivo non-invasively? Kudos to…
0
18
0